Belarus vs Guyana: Cause of death, by non-communicable diseases, ages 5-14, male
Belarus
43.2%
in 2021
Guyana
43.3%
in 2021
Belarus rank
66th
Guyana rank
64th
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Belarus
- Guyana
How they compare
Guyana currently reports 43.3% against 43.2% in Belarus, a difference of 0.1%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Guyana ahead.
Belarus ranks 66th and Guyana ranks 64th of 185 countries.
Across the 3 decades both report, Belarus averaged higher in 1 and Guyana in 2.
Head to head by decade
| Decade | Belarus | Guyana | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 30.6% | 33.4% | 2.8% | Guyana |
| 2010s | 44.9% | 38.9% | 6.0% | Belarus |
| 2020s | 43.8% | 45.0% | 1.2% | Guyana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Belarus or Guyana?
- Guyana, at 43.3% against 43.2% in Belarus as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Belarus and Guyana?
- 0.1%, with Guyana ahead.
- How many years of comparable data are there for Belarus and Guyana?
- 6 years are reported by both, from 2000 to 2021.
- How do Belarus and Guyana rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Belarus ranks 66th and Guyana ranks 64th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.